CONRAD presents new technology combining contraception, HIV and herpes simplex virus-2 prevention

(CONRAD) CONRAD Head of drug delivery, Meredith Clark, Ph.D., today presented preclinical data on a new intravaginal ring that provides contraception as well as HIV-1 and HSV-2 prevention at the 2013 American Association of Pharmaceutical Scientists Annual Meeting and Exposition in San Antonio, Texas.CONRAD's deputy director of clinical research, Marianne Callahan, will also present information on MPTs at the International Conference on Family Planning in Addis Ababa, Ethiopia.
Source: EurekAlert! - Social and Behavioral Science - Category: Global & Universal Source Type: news